Pharma Tech

Metsera backers establish new biotech armed with China-licensed immunology asset

Aug 26, 2026, 10:40 AM

Read Full Article → Metsera backers establish new biotech armed with China-licensed immunology asset

Translate article text

Choose a language and wait for the translated text.

PHP and ARCH have established Sentivera, a biotech that now has an immunology licensing deal with China-based Haisco.